Drug Trial Radar · NCT05304377
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
250
Planned (sponsor's estimate)
Start
May 22, 2022
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Enliven TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Mar 31, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability and determine the recommended dose for further clinical evaluation of ELVN-001 in patients with chronic myeloid leukemia with and without T315I mutations in patients who are relapsed, refractory or intolerant to TKIs.
Conditions
- Chronic Myeloid Leukemia
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive
- Cml
Interventions
ELVN-001Drug
orally once or twice daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1a: Incidence of dose limiting toxicitiesTime frame: 28 days
- Phase 1a: Incidence of adverse events (AEs)Time frame: up to 28 days
- Phase 1a: Incidence of clinically significant laboratory abnormalitiesTime frame: up to 28 days
- Phase 1a: Incidence of clinically significant ECG abnormalitiesTime frame: up to 28 days
- Phase 1b: Incidence of adverse eventsTime frame: up to 3 years
- Phase 1b: Incidence of clinically significant laboratory abnormalitiesTime frame: up to 3 years
- Phase 1b: Incidence of clinically significant ECG abnormalitiesTime frame: up to 3 years
Locations
45 sites in 14 countries. Site status is shown where the registry gives one.
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
Montefiore Medical Center
The Bronx, New York · Recruiting
Oregon Health & Science University-Knight Cardiovascular Institute
Portland, Oregon · Recruiting
The University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
Royal Adelaide Hospital
Adelaide, Australia · Recruiting
UZ Gent
Ghent, Belgium · Recruiting
UZ Leuven
Leuven, Belgium · Recruiting
CHU Liege
Liège, Belgium · Recruiting
University Health Network (UHN) - Princess Margaret Cancer Centre
Toronto, Ontario, Canada · Recruiting
CHU Amiens Picardie Site Sud
Amiens, France · Recruiting
Institut Bergonie - Centre Regional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
Bordeaux, France · Recruiting
CHRU de Lille - Hopital Calmette-Boulevard du Pr Leclercq CHRU Lille
Lille, France · Recruiting
Centre Hospitalier Universitaire (CHU) De Limoges Hopital Dupuytren
Limoges, France · Terminated
Centre Leon Berard
Lyon, France · Recruiting
Centre Hospitalier Lyon Sud
Pierre-Bénite, France · Withdrawn
Uniklinik RWTH Aachen Medizinische
Aachen, Germany · Recruiting
Charite Campus Virchow
Berlin, Germany · Recruiting
Klinikum der Goethe Universitat
Frankfurt, Germany · Recruiting
Universitaetsklinikum Des Saarlandes Und Medizinische Fakultaet Der Universitaet Des Saarlandes
Homburg, Germany · Recruiting
Universitaetsklinikum Jena
Jena, Germany · Recruiting
Medizinische Universitatsklinik Mannheim der Universitat Heidelberg
Mannheim, Germany · Recruiting
Universitaetsmedizin Rostock
Rostock, Germany · Recruiting
Semmelweis Egyetem, Belgyogyaszati es Onkologiai Klinika
Budapest, Hungary · Recruiting
Pecsi Tudomanyegyetem Klinikai Kozpont (University of Pecs, Clinical Centre)
Pécs, Hungary · Recruiting
Hadassah Medical Center
Jerusalem, Israel · Recruiting
The Galilee Medical Center
Nahariya, Israel · Recruiting
Rabin Medical Center
Petah Tikva, Israel · Recruiting
Azienda Ospedaliero Universitaria Delle Marche
Ancona, Italy · Recruiting
Radboud University Medical Center
Nijmegen, Netherlands · Recruiting
Szpital Specjalistycnzy im. Jedrzeja Sniadeckiego w Nowym Saczu
Nowy Sącz, Poland · Recruiting
MICS Centrum Medyczne Torun
Torun, Poland · Recruiting
Instytut Hematologii I Transfuzjologii
Warsaw, Poland · Recruiting
Keimyung University Dongsan Hospital
Daegu, South Korea · Withdrawn
Uijeongbu Eulji Medical Center
Gyeonggi-do, South Korea · Recruiting
Chonnam National University Hwasun Hospital
Hwasun, South Korea · Withdrawn
Samsung Medical Center
Seoul, South Korea · Withdrawn
Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea · Withdrawn
Hospital Del Mar
Barcelona, Spain · Recruiting
Hospital Universitario de Gran Canaria Dr. Negrin, Servicio Canario e Salud (SCS)
Las Palmas de Gran Canaria, Spain · Withdrawn
Hospital Universitario La Paz
Madrid, Spain · Recruiting
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.